Literature DB >> 3887549

Studies of the phospholipase A2 activity of rat ileal mucosa.

C Tagesson, R Sjödahl.   

Abstract

A rapid and simple procedure has been used to determine phospholipase A2 activity (EC 3.1.1.4) in rat ileal mucosa. We used 14C-oleate-labeled Escherichia coli as substrate for the phospholipase activity and a 0.45-micron Millipore filter to separate the product of hydrolysis--the 14C-oleic acid--from the unhydrolyzed substrate. The phospholipase A2 activity was optimal at pH 9.8 and at 2 mM Ca2+, but another peak of activity appeared at pH 7.2. In addition, cell fractionation revealed yet another phospholipase A2 activity at pH 5.0 in the absence of Ca2+. These findings suggest the presence of more than one phospholipase A2 in the ileal mucosa and points to the possible use of a simple procedure for studying their distribution and properties.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887549     DOI: 10.3109/00365528509089628

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Development of phospholipase A2 and lysophosphatidylcholine metabolising enzyme activities in the neonatal rat intestine.

Authors:  C Tagesson; E Telemo; G Ekström; B Weström
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

2.  Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.

Authors:  I Lilja; J Dimberg; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  Characterization of phospholipase A2 activity in aspirates of human pancreatic pseudocysts after isolation by reversed-phase high performance liquid chromatography.

Authors:  B Göke; T Meyer; H Loth; G Adler; R Arnold
Journal:  Klin Wochenschr       Date:  1989-02-01

4.  Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation.

Authors:  T Otamiri; L Franzén; D Lindmark; C Tagesson
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

5.  Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.

Authors:  G Olaison; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

6.  Quinacrine prevention of intestinal ischaemic mucosal damage is partly mediated through inhibition of intraluminal phospholipase A2.

Authors:  T Otamiri
Journal:  Agents Actions       Date:  1988-12

7.  Dexamethasone-induced alterations in lipid composition and fluidity of rat proximal-small-intestinal brush-border membranes.

Authors:  T A Brasitus; P K Dudeja; R Dahiya; A Halline
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.